Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies - GBI Research Reports

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies - GBI Research Reports
Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
Published Sep 01, 2010
156 pages — Published Sep 01, 2010
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research's report, 'Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies', provides the key data and analyzes the major challenges and drivers for the biomanufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biologics. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical and biotech industry.

The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts to provide a comprehensive view of the manufacturing of biologics.

Scope

The scope of this report includes:
- Opportunities and challenges for manufacturers of biologics in the pharmaceuticals industry
- Market revenues and forecasts for biologics manufacturing in the global pharmaceutical industry from 2009 to 2016.
- The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China.
- Processes involving the manufacturing of biologics including upstream and downstream bioprocessing.
- Technology trends in upstream and downstream bioprocessing that shape the biomanufacturing industry and regulatory trends in the key markets.
- Production capacities for the mammalian and microbial manufacturing facilities in the key regions.
- Qualitative analysis of the market drivers, barriers, future outlook and challenges for the manufacturing of biologics in the pharmaceutical industry
- Analysis of competitive landscape and the leading market players.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:
- Formulate strategies to increase your company's growth by understanding the new growth opportunities in the market for manufacturing of biologics
- Work around the regulatory and technology hurdles by identifying the key trends shaping and driving the market for biomanufacturing.
- Differentiate yourself from competitors and develop new solutions for the biomanufacturing industry by understanding the current competitive landscape and how it is evolving to meet the increasing demands
- Draft efficient strategies by understanding best practices, identifying key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Make more informed business decisions from the insightful and in-depth analysis of the market for biomanufacturing by analyzing the key technology trends that shape the growth of this market

  
Source:
Document ID
GBIHC040MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies" Sep 01, 2010. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Manufacturing-of-Biologics-Increasing-Demand-for-Monoclonal-Antibodies-and-Recombinant-Proteins-Drives-Increases-in-Capacities-and-Innovative-Production-Technologies-2115-79>
  
APA:
GBI Research Reports. (2010). Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Sep 01, 2010. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Manufacturing-of-Biologics-Increasing-Demand-for-Monoclonal-Antibodies-and-Recombinant-Proteins-Drives-Increases-in-Capacities-and-Innovative-Production-Technologies-2115-79>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.